Modus Therapeutics Holding: Funding for next step secured – Q3 review
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen
•Kom igång: Börjar investera i fonder inför 2026 – komplett guide för nybörjare

Pressmeddelande

Modus Therapeutics Holding: Funding for next step secured – Q3 review

MFN Publicerad: 28 Nov 15:00

DNB Carnegie has published a new commissioned research report on Modus Therapeutics Holding.

 To access the full report and subscribe to future updates, visit https://access.dnbcarnegie.com/companies/1469

Information
This is a press release from DNB Carnegie. For information about DNB Carnegie commissioned research, see https://access.dnbcarnegie.com/, or contact our commissioned research team at [email protected].

About Us
DNB Carnegie is the leading and independent Nordic investment and private bank. Our operations within Corporate Finance, Securities and Research, Private Banking and Wealth Management are among the market leaders within their respective sectors. Together, they build an unbeatable combination of integrated knowledge, guiding our clients towards better business. DNB Carnegie operates in six countries and has more than 800 employees.

Läses av andra just nu

Senaste nytt